Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the alpha subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death.
Purity:
98.0%
CAS Number:
[1085337-57-0]
Target:
CSF-1R (c-Fms)
* VAT and and shipping costs not included. Errors and price changes excepted
